Riskpilot← Back to searchSign inGet full accessProPharma Group Sweden Holding AB
ABActiveOrg 5590837190Fleminggatan 18Activities of head offices · NACE 7010Est. 20160 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
77.3%
Financial strength
Net profit 2024
SEK -3,2M
+60% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -375K | — |
| Net profit | SEK -3,2M | +60% |
| Total assets | SEK 84,7M | +0% |
| Equity | SEK 65,5M | +1577% |
| Employees | 0 | — |
Legal name
ProPharma Group Sweden Holding AB
Org number
5590837190
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
3 november 2016
Share capital
SEK 70 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska äga och förvalta aktier och övriga värdepapper samt bedriva därmed förenlig verksamhet, tillhandahålla konsulttjänster inom kvalitetssäkring, teknisk support, regulatoriska frågor och biverknings- och säkerhetsfrågor till läkemedels-, medicin-teknik- och hälsovårdsindustrin samt andra relaterade aktiviteter.
Address
Fleminggatan 18
Email
office.se@propharmagroup.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −96 | −100 | −110 | — | −375 |
| Depreciation & amort. | −152 | −152 | −139 | −139 | −13 |
| EBIT | −248 | −252 | −249 | −139 | −388 |
| Net financials | 6 738 | −4 957 | −9 147 | −7 869 | −2 826 |
| Profit before tax | 6 490 | −5 209 | −7 129 | −8 008 | −3 214 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 6 490 | −5 209 | −7 129 | −8 008 | −3 214 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 59 849 | 61 111 | 79 771 | 84 832 | 84 679 |
| Equity | 15 912 | 10 703 | 3 575 | −4 434 | 65 499 |
| Long-term debt | 43 937 | 50 408 | 59 054 | 0 | 0 |
| Short-term debt | 0 | 0 | 17 142 | 89 266 | 19 180 |
| Total debt | 43 937 | 50 408 | 76 196 | 89 266 | 19 180 |
EBITDA margin
-37500000.0%
This company
15.8%
Market median
-237341872% vs market
20202024
Equity ratio
77.3%
This company
38.2%
Market median
+102% vs market
20202024
Return on equity
-4.9%
This company
18.4%
Market median
-127% vs market
20202024
Net profit margin
-321400000.0%
This company
8.1%
Market median
-3967901335% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JJ Chief Executive Officer | Chief Executive Officer | 2024 |
AC Chief Auditor | Chief Auditor | 2021 |
MH Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
| Former (1) | ||
OC Authorized Recipient of Service | Authorized Recipient of Service | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (5) | ||
| Chairman | 2024 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2024 | |
| Chairman | 2021 – 2024 | |
| Board of Directors | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PROPHARMA GROUP EUROPE BV
ProPharma Group Sweden Holding AB Board members of ProPharma Group Sweden Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jason Jon DeGoes | Chief Executive Officer | 0 companies |
| Ove Christian Hofling | Authorized Recipient of Service | 0 companies |
| Anneli Christina Richardson | Chief Auditor | 0 companies |
| Maria Helena Johansson | Authorized Recipient of Service | 0 companies |
| Karl Vishnu Deonanan | Chairman | 0 companies |
| Brian Stephen Tuttle | Chairman | 0 companies |
| Robert Hugh Chestnut | Board of Directors | 0 companies |
| Timothy Joseph Bauwens | Board of Directors | 0 companies |
| Carl Barker | Board of Directors | 0 companies |
| Dawn Gail Sherman | Chairman | 0 companies |
| Jan Johannes Luijendijk | Board of Directors | 0 companies |